Professor of Clinical Medicine
University of California San Diego
San Diego, California
- HIV Infection - Clinical Management
- Antiretroviral Therapy
- HIV and Aging - Cardiovascular Diseases
- HIV and Syphilis
Charles Hicks, MD, is a Professor of Medicine with tenure in the Division of Infectious Diseases at Duke University Medical Center in Durham, North Carolina, USA. He is a graduate of the United States Military Academy at West Point and the George Washington University School of Medicine and did his training in Infectious Diseases at Walter Reed Army Medical Center.
He is currently Principal Investigator and Director of the Interdisciplinary Research Training Program in AIDS at Duke and supports the education and training of postdoctoral basic scientists and clinical research fellows training in HIV-related research. He has served on numerous advisory groups and Data Safety Monitoring Boards for international studies involving antiretroviral therapy and HIV prevention strategies. He serves as a reviewer for NIH grant proposals and for the research submissions at the International Conference on HIV Infection and the International AIDS Society Pathogenesis Meetings. He is also a reviewer for several infectious diseases and HIV journals.
Dr Hicks also provides HIV patient care in the Duke Infectious Diseases Clinic, which cares for over 1800 HIV-infected persons. He is a fellow in the American College of Physicians and in the Infectious Diseases Society of America. He was the recipient of the AB Hoff Memorial Prize Medal and the Bailey K Ashford Clinical Research Award while at Walter Reed. He has also been awarded the Eugene A Stead, Jr Award for excellence in teaching by the house staff of the Duke Department of Medicine.
- Fellow in the American College of Physicians
- Fellow in the Infectious Diseases Society of America
- AB Hoff Memorial Prize Medal for Research Excellence - Walter Reed Army Institute of Research
- Bailey K Ashford Clinical Research Award - Walter Reed Army Medical Center
- Eugene A Stead, Jr Award for excellence in teaching by the house staff of the Duke Department of Medicine
- BS - Engineering - United States Military Academy, West Point, New York
- MD - George Washington University School of Medicine, Washington, D.C.
Hicks C, Clay P, Redfield R, Lalezari J, Liporace R, Schneider S, Sension M, McRae M, Laurent JP. Safety, tolerability, and efficacy of KP-1461 therapy for 124 days in antiretroviral-experienced HIV Type-1-infected subjects. AIDS Research and Human Retroviruses. 2012; epub ahead of print.
Hicks CB, DeJesus E, Sloan LM, et al. Comparison of once-daily fosamprenavir boosted with either 100mg or 200mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758. AIDS Research and Human Retroviruses. 2009;25:395-403.
Hicks C, Gulick R. Raltegravir – the First HIV Integrase Inhibitor. Clin Infect Dis. 2009;48:931-9.
Mugavero M, Castellano C, Edelman D, Hicks C. Late diagnosis of HIV infection: the role of age and sex. Am J Med. 2007;120:370-3.
Hicks C, Cahn P, Cooper D, et al. Durable efficacy of tipranavir/ritonavir in combination with an optimized background of antiretrovirals for treatment-experienced HIV-1-infected patients at 48-weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials. Lancet. 2006;368:466-75.